Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint TherapyKathrin Renner, Marina Kreutz, Christina Bruß et al.|Cell Reports|2019Cited by 297
A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapyChristoph K. Stein‐Thoeringer, Eran Elinav, Maria‐Luisa Schubert et al.|Nature Medicine|2023Cited by 226